Features of tryptophan kynurenine pathway metabolites alterations in coronary artery disease and heart failure

被引：0
|
作者：
Alieva, R. B. Rano [1 ]
Fozilov, K. H. G. [1 ]
Belenkov, Y. U. N. [2 ]
Khabarova, N. V. [2 ]
Ageev, A. A. [2 ]
Appolonova, S. A. [2 ]
Kozhevnikova, M. V. [2 ]
机构：
[1] Republican Specialized Sci Pract Med Ctr Cardiol, Tashkent, Uzbekistan
[2] IM Sechenov First Moscow State Med Univ, Innovat Sci Sch, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：626 / 627
页数：2
相关论文
共 50 条
  • [31] Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease
    Liang, Yuqing
    Xie, Shan
    He, Yanyun
    Xu, Manru
    Qiao, Xi
    Zhu, Yue
    Wu, Wenbin
    DISEASE MARKERS, 2022, 2022
  • [32] Coronary Artery Fistula: Association between Pathway Patterns, Clinical Features and Congenital Heart Disease
    Cobo, Daniel L.
    Batigalia, Fernando
    Croti, Ulisses A.
    Sciarra, Adilia M. P.
    Foss, Marcos H. D.
    Cobo, Rafaela G. F.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (01) : 84 - 88
  • [33] The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease
    Eirik W. Rebnord
    Elin Strand
    Øivind Midttun
    Gard F.T. Svingen
    Monika H.E. Christensen
    Per M. Ueland
    Gunnar Mellgren
    Pål R. Njølstad
    Grethe S. Tell
    Ottar K. Nygård
    Eva R. Pedersen
    Diabetologia, 2017, 60 : 1712 - 1721
  • [34] The kynurenine: tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease
    Rebnord, Eirik W.
    Strand, Elin
    Midttun, Oivind
    Svingen, Gard F. T.
    Christensen, Monika H. E.
    Ueland, Per M.
    Mellgren, Gunnar
    Njolstad, Pal R.
    Tell, Grethe S.
    Nygard, Ottar K.
    Pedersen, Eva R.
    DIABETOLOGIA, 2017, 60 (09) : 1712 - 1721
  • [35] Heart Failure With Obstructive, Nonobstructive, and No Coronary Artery Disease
    Shaw, Leslee J.
    Arbustini, Eloisa
    Narula, Jagat
    JACC-HEART FAILURE, 2019, 7 (06) : 502 - 504
  • [36] Heart failure control in patient with coronary artery disease
    Mosteoru, S. L. Svetlana Liliana
    Pleava, R.
    Totorean, C.
    Dumitrescu, A.
    Gaita, L.
    Gaita, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 555 - 555
  • [37] Sexuality in patients with coronary artery disease and heart failure
    Bernardo, A
    HERZ, 2001, 26 (05) : 353 - 359
  • [38] Left heart failure and coronary artery disease in COPD
    Beauvais, F
    Logeart, D
    Tartière, JM
    Bouvier, E
    Cohen-Solal, A
    REVUE DES MALADIES RESPIRATOIRES, 2003, 20 (06) : S39 - S44
  • [39] Heart failure therapy in patients with coronary artery disease
    Taylor, Clare J.
    Hobbs, F. D. Richard
    CURRENT OPINION IN PHARMACOLOGY, 2013, 13 (02) : 205 - 209
  • [40] The Metabolic Treatment of Coronary Artery Disease and Heart Failure
    Di Napoli, Pericle
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (08) : 826 - 826
12345